Chronic Tubulointerstitial Disease


Primary interstitial kidney disease comprises a diverse group of disorders that elicit interstitial inflammation associated with tubular damage. Traditionally, interstitial nephritis has been classified morphologically and clinically into acute and chronic forms. Acute interstitial nephritis (AIN) generally induces rapid deterioration in kidney function with a marked interstitial inflammatory response characterized by mononuclear cell infiltration with or without eosinophils, interstitial edema, and varying degrees of tubular cell injury. This process typically spares both glomerular and vascular structures, and is discussed more fully in Chapter 33. By contrast, chronic interstitial nephritis (CIN) follows a more indolent course and is characterized by interstitial fibrosis, tubular atrophy, and most often an interstitial mononuclear cell infiltrate. Over time, glomerular and vascular structures are involved, with progressive parenchymal fibrosis and sclerosis. Overlap can occur between these two clinical conditions; AIN sometimes presents as a more insidious disease with progression to chronic kidney disease (CKD). Similarly, some forms of CIN are associated with acute tubular cell injury.

Histopathology

The histopathology of CIN is remarkably consistent despite the varied causes ( Box 43.1 ). CIN is characterized by the development of tubular atrophy with interstitial fibrosis typically with associated predominantly mononuclear cell inflammation with or without inflammation in atrophied tubules ( Fig. 43.1 ). Certain forms of CIN may have minimal inflammation (e.g., lead, lithium) or have interstitial granulomas (e.g., sarcoidosis). Glomerular and vascular structures may be relatively preserved early in the course of disease but ultimately become involved in progressive sclerosis and fibrosis. Ongoing development of tubulointerstitial fibrosis is observed in all forms of progressive kidney disease, including primary tubulointerstitial, glomerular, and vascular disorders, as a final common pathway to kidney failure.

BOX 43.1
Chronic Interstitial Nephritis

Drugs/Toxins

  • Analgesics

  • Heavy metals (lead, cadmium, mercury)

  • Lithium

  • Chinese herbs (aristolochic acid)

  • Calcineurin inhibitors (cyclosporine, tacrolimus)

  • Cisplatin

  • Nitrosoureas

  • Herbicides (glyphosate, paraquat, others)

Hereditary Disorders

  • Polycystic kidney disease

  • Medullary cystic disease–juvenile nephronophthisis

  • Hereditary nephritis

  • Karyomegalic interstitial nephritis

Metabolic Disturbances

  • Hypercalcemia/nephrocalcinosis

  • Hypokalemia

  • Hyperuricemia

  • Hyperoxaluria

  • Cystinosis

Immune-Mediated Disorders

  • Kidney allograft rejection

  • Systemic lupus erythematosus

  • Sarcoidosis

  • Granulomatosis with polyangiitis (Wegener granulomatosis)

  • Vasculitis

  • Sjögren syndrome

  • Tubulointerstitial nephritis and uveitis (TINU) syndrome

  • IgG4 disease

  • Anti-low-density lipoprotein receptor-related protein 2 (LRP2) nephropathy

Hematologic Disturbances

  • Multiple myeloma

  • Light chain disease

  • Dysproteinemias

  • Lymphoproliferative disease

  • Sickle cell disease

Infections

  • Kidney

  • Systemic

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here